Page last updated: 2024-09-03

rhenium-186 hedp and Cancer of Lung

rhenium-186 hedp has been researched along with Cancer of Lung in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, K; Li, S; Liu, J; Tanada, S; Tian, M; Zhang, H	1
Anagnostopoulou, US; Datseris, EI; Leondi, AH; Leontopoulou, SA; Papadaki, EK; Rapti, AS; Souvatzoglou, MA; Zerva, CJ	1
Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A	1

Trials

1 trial(s) available for rhenium-186 hedp and Cancer of Lung

Article	Year
Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:3 Topics: Bone Neoplasms; Carcinoma; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Patient Selection; Radiopharmaceuticals; Treatment Outcome	2004

Article

Year

Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:3

Topics: Bone Neoplasms; Carcinoma; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Patient Selection; Radiopharmaceuticals; Treatment Outcome

2004

Other Studies

2 other study(ies) available for rhenium-186 hedp and Cancer of Lung

Article	Year
Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:5 Topics: Adult; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Radionuclide Imaging; Rhenium	2003
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases. Annals of nuclear medicine, 2000, Volume: 14, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium	2000

Article

Year

Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.

Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:5

Topics: Adult; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Radionuclide Imaging; Rhenium

2003

Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.

Annals of nuclear medicine, 2000, Volume: 14, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium

2000